GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CeriBell Inc (NAS:CBLL) » Definitions » Inventories, Raw Materials & Components

CBLL (CeriBell) Inventories, Raw Materials & Components : $4.09 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CeriBell Inventories, Raw Materials & Components?

CeriBell's inventories, raw materials & components for the quarter that ended in Dec. 2024 was $4.09 Mil.

CeriBell's quarterly raw materials declined from Jun. 2024 ($4.14 Mil) to Sep. 2024 ($3.99 Mil) but then increased from Sep. 2024 ($3.99 Mil) to Dec. 2024 ($4.09 Mil).

CeriBell's annual raw materials increased from Dec. 2022 ($2.04 Mil) to Dec. 2023 ($3.41 Mil) and increased from Dec. 2023 ($3.41 Mil) to Dec. 2024 ($4.09 Mil).


CeriBell Inventories, Raw Materials & Components Historical Data

The historical data trend for CeriBell's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CeriBell Inventories, Raw Materials & Components Chart

CeriBell Annual Data
Trend Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
2.04 3.41 4.09

CeriBell Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial - 3.41 4.14 3.99 4.09

CeriBell Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


CeriBell Business Description

Industry
Traded in Other Exchanges
N/A
Address
360 N. Pastoria Avenue, Sunnyvale, CA, USA, 94085
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.